New hope to stop blood Cancer's return after transplant
NCT ID NCT07449286
Summary
This study is testing whether a drug called interferon-α can help prevent cancer from coming back in patients with high-risk forms of leukemia or myelodysplastic syndrome (MDS) who have just received a stem cell transplant. It will involve 100 patients aged 12-65 who have a specific genetic mutation (TP53) and currently show no signs of remaining cancer. The main goal is to see if this treatment lowers the chance of the disease returning.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELODYSPLASTIC SYNDROMES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Peking University People's Hospital, Peking University Institute of Hematology
Beijing, Beijing Municipality, 100044, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.